Simon Fraser University
🇨🇦Canada
Clinical Trials
31
Active:0
Completed:21
Trial Phases
4 Phases
Phase 1:1
Phase 2:2
Phase 4:1
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (31 trials with phase data)• Click on a phase to view related trials
Not Applicable
27 (87.1%)Phase 2
2 (6.5%)Phase 1
1 (3.2%)Phase 4
1 (3.2%)Real-time Feedback in Swimming: Workout Compliance and Swimming Performance Outcomes Using Smart Swim Goggles
Not Applicable
Completed
- Conditions
- Effect of Real-time Visual Feedback on Participant Compliance, Motivation, and Performance in Swimming
- First Posted Date
- 2024-08-15
- Last Posted Date
- 2024-08-15
- Lead Sponsor
- Simon Fraser University
- Target Recruit Count
- 57
- Registration Number
- NCT06556212
- Locations
- 🇨🇦
St. George's Senior School, Vancouver, British Columbia, Canada
Running Online Injury Prevention Feasibility Study
Not Applicable
Not yet recruiting
- Conditions
- Musculoskeletal Injury
- First Posted Date
- 2024-08-05
- Last Posted Date
- 2024-08-05
- Lead Sponsor
- Simon Fraser University
- Target Recruit Count
- 60
- Registration Number
- NCT06538363
- Locations
- 🇨🇦
Simon Fraser University, Burnaby, British Columbia, Canada
Impact of Blood Phobia on Fainting Susceptibility
Not Applicable
Recruiting
- Conditions
- Syncope, VasovagalBlood, Injection, Injury Type Phobia
- First Posted Date
- 2024-03-28
- Last Posted Date
- 2025-05-15
- Lead Sponsor
- Simon Fraser University
- Target Recruit Count
- 20
- Registration Number
- NCT06336031
- Locations
- 🇨🇦
Simon Fraser University, Burnaby, British Columbia, Canada
Accessing Innovative Mental Health Services for Depression in Vietnam
Not Applicable
Not yet recruiting
- Conditions
- DepressionAnxiety Disorders
- First Posted Date
- 2023-03-24
- Last Posted Date
- 2023-03-24
- Lead Sponsor
- Simon Fraser University
- Target Recruit Count
- 336
- Registration Number
- NCT05783531
NO AD: Use of Nitric Oxide (NO) Donors for the Prevention of Autonomic Dysreflexia (AD) During Bowel Care Following SCI
Phase 2
Not yet recruiting
- Conditions
- Spinal Cord InjuriesAutonomic Dysreflexia
- Interventions
- Drug: Glyceryl Trinitrate Only Product in Oromucosal Dose FormOther: Placebo sublingual spray
- First Posted Date
- 2022-12-02
- Last Posted Date
- 2024-11-28
- Lead Sponsor
- Simon Fraser University
- Target Recruit Count
- 26
- Registration Number
- NCT05635851
- Prev
- 1
- 2
- 3
- 4
- 5
- 6
- Next
News
Brain Imaging Reveals Why Parkinson's Drug Levodopa Fails Some Patients
Simon Fraser University researchers used advanced MEG brain imaging to discover why levodopa, the primary Parkinson's drug, works differently across patients.